Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease
Journal of Clinical Psychopharmacology - United States
doi 10.1097/jcp.0b013e3181b2ac0a
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)